Zusammenfassung
Es gibt eine beachtliche Anzahl psychiatrischer Patienten, denen mit herkömmlicher pharmakologischer Behandlung oder Psychotherapie nicht geholfen werden kann. Insbesondere Ergebnisse aus der funktionellen Bildgebung haben zur Entwicklung der tiefen Hirnstimulation (THS) geführt. In diesem Beitrag wird die Anwendung der THS bei therapieresistenter Depression und Zwang beschrieben und die Auswahl verschiedener Ziele diskutiert. Erste Studien haben gezeigt, dass mithilfe der THS dysfunktionale neuronale Netze bei Depression und Zwang moduliert werden können. Dies macht die THS zu einer zukunftsträchtigen Methode in der Behandlung therapieresistenter Depression und Zwang.
Abstract
A substantial number of patients suffering from severe neuropsychiatric disorders do not respond to conventional therapeutic approaches. Results from functional neuroimaging research have led to novel putative strategies. Recently, one of these methods, deep brain stimulation (DBS) has been applied in selected patient with major depression and obsessive-compulsive disorder (OCD). In this article, reasons for the use of DBS in psychiatry are discussed. Also, the selection of different targets for major depression and OCD are described. First results have demonstrated that DBS might be able to modulate dysfunctional neural networks in both major depression and OCD. In the actual state of research, DBS can be considered as a valuable therapy option for therapy-resistant patients.
Schlüsselwörter
tiefe Hirnstimulation - Depression - Zwang
Key words
deep brain stimulation - depression - obsessive compulsive disorders
Literatur
1
Keller M B, Lavori P W, Mueller T I. et al .
Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects.
Arch Gen Psychiatry.
1992;
49
809-816
2
Rush A J, Trivedi M H, Wisniewski S R. et al .
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
Am J Psychiatry.
2006;
163
1905-1917
3
Murray C J, Lopez A D.
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.
Lancet.
1997;
349
1436-1442
4 Greenberg B, Malone D. Preliminary results from DBS multicenter study in depression. In: Providence. Rhode Island; Personal Communication 2007
5
Mayberg H S, Lozano A M, Voon V. et al .
Deep brain stimulation for treatment-resistant depression.
Neuron.
2005;
45
651-660
6
Schlaepfer T E, Cohen M X, Frick C. et al .
Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression.
Neuropsychopharmacology.
2007;
33
368-377
7
Aouizerate B, Cuny E, Martin-Guehl C. et al .
Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report.
Journal of Neurosurgery.
2004;
101
574-575
8
Jiménez F, Velasco F, Salin-Pascual R. et al .
A patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle.
Journal of Neurosurgery.
2005;
57
585-593
9
Abelson J L, Curtis G C, Sagher O. et al .
Deep brain stimulation for refractory obsessive-compulsive disorder.
Biol Psychiatry.
2005;
57
510-516
10
Anderson D, Ahmed A.
Treatment of patients with intractable obsessive-compulsive disorder with anterior capsular stimulation. Case report.
J Neurosurg.
2003;
98
1104-1108
11
Gabriels L, Cosyns P, Nuttin B. et al .
Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases.
Acta Psychiatr Scand.
2003;
107
275-282
12
Nuttin B, Cosyns P, Demeulemeester H. et al .
Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder.
Lancet.
1999;
354
1526
13
Nuttin B J, Gabriels L A, Cosyns P R. et al .
Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder.
Neurosurgery.
2003;
52
1263-1272; discussion 1272–1274
14
Sturm V, Lenartz D, Koulousakis A. et al .
The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders.
J Chem Neuroanat.
2003;
26
293-299
15
Mallet L, Mesnage V, Houeto J L. et al .
Compulsions, Parkinson's disease, and stimulation.
Lancet.
2002;
360
1302-1304
16
Fontaine D, Mattei V, Borg M. et al .
Effect of subthalamic nucleus stimulation on obsessive-compulsive disorder in a patient with Parkinson disease. Case report.
J Neurosurg.
2004;
100
1084-1086
17
Kühn J, Huff W, Lee S-H. et al .
Tiefenhirnstimulation bei psychiatrischen Erkrankungen.
Fortschritte der Neurologie und Psychiatrie.
2007;
75
447-457
18
Greenberg B D, Malone D A, Friehs G M. et al .
Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder.
Neuropsychopharmacology.
2006;
31
2384-2393
Dr. Bettina Bewernick
AG Hirnstimulation, Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Bonn
Sigmund-Freud-Str. 25
53105 Bonn
Email: Bettina.Bewernick@ukb.uni-bonn.de